Home   >  
Apoptosis Pathway
  >  
c Myc

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

c Myc

Chemical Structure Cat. No. Product Name CAS No.
NY2267 Chemical Structure
BCP41938 NY2267 886053-73-2
NY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM.
EN4 Chemical Structure
BCP40015 EN4 1197824-15-9
EN4 is a functional Covalent Ligand Targeting an Intrinsically Disordered Cysteine within MYC.
MYCi975 Chemical Structure
BCP34062 MYCi975 2289691-01-4
MYCi975 is an orally active MYC inhibitor, which disrupts MYC/MAX interaction, promotes MYC T58 phosphorylation and MYC degradation, and impairs MYC driven gene expression.
MYCi361 Chemical Structure
BCP34061 MYCi361 2289690-31-7
MYCi361 is a MYC inhibitor with the Kd of 3.2 μM for binding to MYC.
10058-F4 Chemical Structure
BCP08097 10058-F4 403811-55-2
10058-F4 is a specific c-Myc inhibitor that disrupts the association between the c-Myc and Max, inhibits HL60 cell growth with IC50 of 51 uM.
CBL0137 Chemical Structure
BCP29977 CBL0137 1197996-80-7
CBL0137 is a metabolically stable curaxin that activates p53 with an EC50 value of 0.37 μM and inhibits NF-κB with an EC50 of 0.47 μM.
10074-G5 Chemical Structure
BCP09223 10074-G5 413611-93-5
10074-G5 is an inhibitor of c-Myc-Max dimerization with an IC50 of 146 μM.
ML-327 Chemical Structure
BCP29132 ML-327 1883510-31-3
ML327 is a blocker of MYC which can also de-repress E-cadherin transcription and reverse Epithelial-to-Mesenchymal Transition (EMT).
0086-13720134139